Total Funding
68
59
Total FundingPost-IPO Debt raised
Growth Score
-9 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
180650
Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.
- Hendrik Nogai: Chief Medical Officer
- Pawel Przewiezlikowski: Chief Executive Officer & Co-founderPast Role: Grupa Interia.pl Sp. z o.o, Founder, CEO
About the Company
Ryvu is a biopharmaceutical company developing small-molecule therapies that address the clinical limitations of current treatments in oncology.
